Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysisBingbing Cong, Jean‐Sébastien Casalegno, Uğurcan Koç et al.|The Lancet Infectious Diseases|2023Cited by 104
Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025Vânia Gaio, Beatriz Sousa, Margarida Freitas et al.|Influenza and Other Respiratory Viruses|2025Cited by 2
RSV-bacterial co-infection is associated with increased illness severity in hospitalized children - Results from a prospective sentinel surveillance studyAna Rita Torres, VigiRSV group, Vânia Gaio et al.|Research Square|2023Cited by 0
Author response for "Nirsevimab effectiveness against RSV-related hospitalisations in children under 24 months: a test-negative case–control study in Portugal, 2024–2025"Vânia Gaio, VigiRSV group, Camila Henriques et al.|Unknown|2025Cited by 0